Newly emerging metronidazole-resistant Clostridioides difficile PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023.

IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES
Jaroslava Zikova, Klaudia Szarek, Monika Kabała, Dorota Wultańska, Natalia Frankowska, Adam Iwanicki, Krzysztof Hinc, Anna Mucha, Jolanta Komarnicka, Anna Jagielska, Ed Kuijper, Marcela Krutova, Hanna Pituch
{"title":"Newly emerging metronidazole-resistant <i>Clostridioides difficile</i> PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023.","authors":"Jaroslava Zikova, Klaudia Szarek, Monika Kabała, Dorota Wultańska, Natalia Frankowska, Adam Iwanicki, Krzysztof Hinc, Anna Mucha, Jolanta Komarnicka, Anna Jagielska, Ed Kuijper, Marcela Krutova, Hanna Pituch","doi":"10.2807/1560-7917.ES.2025.30.21.2400675","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundOn 29 January 2024, the European Centre for Disease Prevention and Control distributed an alert about a metronidazole-resistant <i>Clostridioides difficile</i> outbreak of PCR ribotype (RT) 955 in England.AimWe aimed to investigate the presence of RT955 in Czech, Slovak and Polish <i>C. difficile</i> isolates and evaluate different culture media for detecting its metronidazole resistance.MethodsIsolates with binary toxin genes identified as 'unknown' by the WEBRIBO PCR ribotyping database up to 2023 were re-analysed after adding the RT955 profile to the database. The RT955 isolates were characterised by whole genome sequencing and tested for susceptibility to 15 antimicrobials.ResultsWe did not find RT955 in Czech (n = 6,661, 2012-2023) and Slovak (n = 776, 2015-2023) isolates, but identified 13 RT955 cases (n = 303, 2021-2023) in three hospitals in Poland. By whole genome multilocus sequence typing, 10 isolates clustered into one clonal complex including a sequence of United Kingdom strain ERR12670107, and shared similar antimicrobial resistance genes/mutations. All 13 isolates were resistant to ciprofloxacin/moxifloxacin, erythromycin/clindamycin and ceftazidime. All isolates had a mutation in the <i>nim</i>B gene promoter and in NimB (Tyr130Ser and Leu155Ile). The metronidazole resistance was detected in all isolates using brain-heart-infusion agar supplemented with haemin and Chocolate agar. Results were discrepant with the European Committee on Antimicrobial Susceptibility Testing-recommended Fastidious anaerobe agar and Brucella blood agar.ConclusionThe identification of clonally related haem-dependent metronidazole-resistant <i>C. difficile</i> RT955 in multiple hospitals indicates a need for prospective surveillance to estimate its prevalence in Europe.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 21","pages":""},"PeriodicalIF":9.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124108/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurosurveillance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2807/1560-7917.ES.2025.30.21.2400675","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundOn 29 January 2024, the European Centre for Disease Prevention and Control distributed an alert about a metronidazole-resistant Clostridioides difficile outbreak of PCR ribotype (RT) 955 in England.AimWe aimed to investigate the presence of RT955 in Czech, Slovak and Polish C. difficile isolates and evaluate different culture media for detecting its metronidazole resistance.MethodsIsolates with binary toxin genes identified as 'unknown' by the WEBRIBO PCR ribotyping database up to 2023 were re-analysed after adding the RT955 profile to the database. The RT955 isolates were characterised by whole genome sequencing and tested for susceptibility to 15 antimicrobials.ResultsWe did not find RT955 in Czech (n = 6,661, 2012-2023) and Slovak (n = 776, 2015-2023) isolates, but identified 13 RT955 cases (n = 303, 2021-2023) in three hospitals in Poland. By whole genome multilocus sequence typing, 10 isolates clustered into one clonal complex including a sequence of United Kingdom strain ERR12670107, and shared similar antimicrobial resistance genes/mutations. All 13 isolates were resistant to ciprofloxacin/moxifloxacin, erythromycin/clindamycin and ceftazidime. All isolates had a mutation in the nimB gene promoter and in NimB (Tyr130Ser and Leu155Ile). The metronidazole resistance was detected in all isolates using brain-heart-infusion agar supplemented with haemin and Chocolate agar. Results were discrepant with the European Committee on Antimicrobial Susceptibility Testing-recommended Fastidious anaerobe agar and Brucella blood agar.ConclusionThe identification of clonally related haem-dependent metronidazole-resistant C. difficile RT955 in multiple hospitals indicates a need for prospective surveillance to estimate its prevalence in Europe.

新发现的耐甲硝唑艰难梭菌PCR核糖型955在波兰(2021年至2023年)发现,在捷克(2012年至2023年)和斯洛伐克(2015年至2023年)未发现。
背景:2024年1月29日,欧洲疾病预防控制中心发布了关于在英国爆发的甲硝唑耐药艰难梭菌PCR核糖型(RT) 955疫情的警报。目的调查捷克、斯洛伐克和波兰艰难梭菌分离株中RT955的存在情况,并评价不同培养基对甲硝唑的耐药性。方法将2023年之前WEBRIBO PCR核糖分型数据库中鉴定为“未知”二元毒素基因的分离株加入RT955基因图谱后进行重新分析。采用全基因组测序对分离株RT955进行鉴定,并对15种抗菌素进行敏感性检测。结果在捷克(2012-2023年,n = 6661)和斯洛伐克(2015-2023年,n = 776)分离株中未发现RT955,但在波兰的三家医院中发现了13例RT955病例(n = 303, 2021-2023年)。通过全基因组多位点序列分型,10株分离株聚集在一个克隆复合体中,包括英国菌株ERR12670107的一个序列,具有相似的耐药基因/突变。13株分离株均对环丙沙星/莫西沙星、红霉素/克林霉素和头孢他啶耐药。所有分离株均在nimB基因启动子和nimB (Tyr130Ser和Leu155Ile)中发生突变。用脑心灌注琼脂补充血红蛋白和巧克力琼脂检测各分离株对甲硝唑的耐药性。结果与欧洲抗菌药物敏感性试验委员会推荐的厌氧菌琼脂和布鲁氏菌血琼脂存在差异。结论多家医院克隆相关血液依赖甲硝唑耐药艰难梭菌RT955的发现表明,需要对其进行前瞻性监测,以估计其在欧洲的流行情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Eurosurveillance
Eurosurveillance INFECTIOUS DISEASES-
CiteScore
32.70
自引率
2.10%
发文量
430
审稿时长
3-8 weeks
期刊介绍: Eurosurveillance is a European peer-reviewed journal focusing on the epidemiology, surveillance, prevention, and control of communicable diseases relevant to Europe.It is a weekly online journal, with 50 issues per year published on Thursdays. The journal includes short rapid communications, in-depth research articles, surveillance reports, reviews, and perspective papers. It excels in timely publication of authoritative papers on ongoing outbreaks or other public health events. Under special circumstances when current events need to be urgently communicated to readers for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Additionally, topical compilations and special issues may be provided in PDF format.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信